Recipharm Completes China-Focused Serialization Project
Recipharm has completed a serialization project for China on behalf of one of its customers.
CDMO Recipharm announced that it is ready for serialization following the completion of a complex serialization project for China on behalf of one of its customers. China’s new serialization legislation offers zero flexibility. Chinese regulators require full compliance and strict importation deadlines have been enforced.
Recipharm has developed a solution to ensure compliance with China’s serialization regulations and has supplied 57 serialized batches since February 2014. A new technology was applied to ensure that each individual box has its own one-dimensional barcode and unique serial number.
Source: Recipharm
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
